Minimed 670G System
Device
Medtronic MiniMed, Inc.
Total Payments
$34.5M
Transactions
37,711
Doctors
6,799
Companies
3
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2021 | $5.6M | 1,976 | 943 |
| 2020 | $9.6M | 4,783 | 1,477 |
| 2019 | $12.0M | 9,440 | 2,740 |
| 2018 | $6.2M | 12,850 | 3,358 |
| 2017 | $1.1M | 8,662 | 3,046 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $30.7M | 1,842 | 88.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $2.0M | 787 | 5.9% |
| Food and Beverage | $940,283 | 30,581 | 2.7% |
| Travel and Lodging | $833,088 | 4,466 | 2.4% |
| Consulting Fee | $16,818 | 6 | 0.0% |
| Space rental or facility fees (teaching hospital only) | $15,545 | 18 | 0.0% |
| Grant | $8,680 | 7 | 0.0% |
| Charitable Contribution | $300.00 | 1 | 0.0% |
| Education | $50.84 | 3 | 0.0% |
Payments by Type
Research
$30.7M
1,842 transactions
General
$3.9M
35,869 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| CEP 304 670G Outcomes Study | Medtronic MiniMed, Inc. | $18.0M | 4 |
| CIP321 AHCL Pivotal Study | Medtronic MiniMed, Inc. | $5.9M | 4 |
| CIP321 AHCL Pivotal Study | Medtronic, Inc. | $4.4M | 6 |
| CEP304 HCL Outcomes Study | Medtronic, Inc. | $1.2M | 6 |
| Investigator Sponsored Research | Medtronic MiniMed, Inc. | $1.1M | 1 |
Top Doctors Receiving Payments for Minimed 670G System
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Mineola, NY | $30.6M | 1,816 |
| , MD | Pediatric Endocrinology | West Covina, CA | $1.0M | 760 |
| , M.D | Pediatrics | Osseo, MN | $280,105 | 455 |
| , M.D | Pediatrics | New Haven, CT | $147,651 | 201 |
| , M.D | Endocrinology, Diabetes & Metabolism | Little Rock, AR | $127,945 | 302 |
| , M.D | Endocrinology, Diabetes & Metabolism | Atlanta, GA | $105,937 | 256 |
| , M.D | Endocrinology, Diabetes & Metabolism | Austin, TX | $73,466 | 103 |
| , MD | Endocrinology, Diabetes & Metabolism | Renton, WA | $70,267 | 97 |
| , MD | Pediatrics | Palo Alto, CA | $46,008 | 25 |
| , D.O | Internal Medicine | Winter Haven, FL | $43,052 | 111 |
| , MD | Pediatric Endocrinology | New Haven, CT | $41,992 | 51 |
| , DO | Emergency Medicine | Plattsburgh, NY | $39,013 | 99 |
| , M.D., M.P.H | Endocrinology, Diabetes & Metabolism | East Setauket, NY | $38,594 | 53 |
| , M.D | Specialist | Escondido, CA | $23,102 | 14 |
| , MD | Pediatric Endocrinology | New Haven, CT | $22,184 | 37 |
| , MD | Endocrinology, Diabetes & Metabolism | Saint Paul, MN | $20,972 | 45 |
| , M.D., PH.D | Internal Medicine | New Haven, CT | $19,802 | 32 |
| , MD | Endocrinology, Diabetes & Metabolism | Northfield, NJ | $18,387 | 21 |
| , MD | Pediatric Endocrinology | Tampa, FL | $17,149 | 64 |
| , MD | Pediatric Endocrinology | Minneapolis, MN | $16,412 | 12 |
| , MD | Endocrinology, Diabetes & Metabolism | Rochester, NY | $16,300 | 18 |
| , MD | Family Medicine | Grand Forks, ND | $15,899 | 32 |
| , MD | Endocrinology, Diabetes & Metabolism | Minneapolis, MN | $15,032 | 25 |
| , MD | Endocrinology, Diabetes & Metabolism | Aurora, CO | $15,019 | 41 |
| , M.D | Internal Medicine | Winston Salem, NC | $14,688 | 82 |
Ad
Manufacturing Companies
- Medtronic MiniMed, Inc. $28.9M
- Medtronic, Inc. $5.6M
- Medtronic USA, Inc. $14.36
Product Information
- Type Device
- Total Payments $34.5M
- Total Doctors 6,799
- Transactions 37,711
About Minimed 670G System
Minimed 670G System is a device associated with $34.5M in payments to 6,799 healthcare providers, recorded across 37,711 transactions in the CMS Open Payments database. The primary manufacturer is Medtronic MiniMed, Inc..
Payment data is available from 2017 to 2021. In 2021, $5.6M was paid across 1,976 transactions to 943 doctors.
The most common payment nature for Minimed 670G System is "Unspecified" ($30.7M, 88.8% of total).
Minimed 670G System is associated with 5 research studies, including "CEP 304 670G Outcomes Study" ($18.0M).